Calin Pop, Ionut Ferent


Introduction: The coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with an inflammatory and prothrombotic state that increases the risk of thromboembolic events. High levels of D-dimer are associated with the severity of the disease and acute pulmonary embolism (PE) is the most common thrombotic complication.

Material and methods: We analyzed a series of four cases of COVID-19 in young patients (under 45 years) who developed PE with a delay of two to four weeks after hospital discharge.

Results: These patients had elevated D-dimer (at least 10 times the upper limit of normal) at the initial admission and at the time of the PE diagnostic, while other parameters which involved inflammation and coagulation (C-reactive protein—CRP; lactate dehydrogenase—LDH; fibrinogen; international normalized ratio—INR) were normal. There were no pre-existing risk factors for PE and all the patients were anticoagulated with prophylactic intermediate doses of enoxaparin.

Conclusions: PE is a complication of the COVID-19 disease which may occur later, especially in young patients with no other risk factors for the condition. The highly elevated levels of D-dimer at COVID-19 admission seem to be associated with the post-discharge apparition of PE. This data suggests the role of extended anticoagulation in selected COVID-19 patients and warrants further investigations.


D-dimer, COVID-19, young patients, pulmonary embolism, post discharge

Full Text:



Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel Coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421–4. doi: 10.1111/jth.14830.


Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020;18(7):1559–61. doi: 10.1111/jth.14849.

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endotheliosis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020;383(2):120-128. doi: 10.1056/NEJMoa2015432.


Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course, and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054-62. doi: 10.1016/S0140-6736(20)30566-3.


Desai R., Gandhi Z., Singh S, Sachdeva S, Manaktala P, Savan S, et al. Prevalence of pulmonary embolism in COVID-19: a pooled analysis. SN Compr Clin Med. 2020:1-4. doi: 10.1007/s42399-020-00605-5. Epub ahead of print.


Vadukul P, Sharma DS, Vincent P. Massive pulmonary embolism following recovery from COVID-19 infection: Inflammation, thrombosis, and the role of extended thromboprophylaxis. BMJ Case Rep. 2020;13(9):e238168. doi: 10.1136/bcr-2020-238168.


Oflar E, Caglar FN. Pulmonary embolism after successful COVID-19 treatment. Int J Cardiovasc Acad. 2020; 6(3):137–9.doi: 10.4103/IJCA.IJCA_24_20

Di Tano G, Moschini L, Loffi M, Testa S, Danzi GB. Late pulmonary embolism after COVID-19 pneumonia despite adequate rivaroxaban treatment. Eur J Case Rep Intern Med. 2020;7(7):001790. doi:10.12890/2020_001790

Karolyi M, Pavelka E, Omid S, Kelani H, Mader T, Baumgartner S, et al. Late-onset pulmonary embolism in young male otherwise healthy COVID-19 patients. Eur J Clin Microbiol Infect Dis. 2021;40(3):633-5. doi: 10.1007/s10096-020-04044-x. Epub 2020 Sep 23.


Vechi HT, Maia LR, Alves MDM. Late acute pulmonary embolism after mild Coronavirus disease 2019 (COVID-19): A case series. Rev Inst Med Trop Sao Paulo. 2020 ;62:e63. doi: 10.1590/S1678-9946202062063.


Greenan-Barrett J, Perera A. COVID-19 and Pulmonary Emboli: A case series and literature review. Clin Pract Cases Emerg Med. 2020;4(3):299–303. doi: 10.5811/cpcem.2020.7.48174.


Beckman, M., Nyrén, S, Kistner, A. A case report of widespread pulmonary embolism in a middle-aged male seven weeks after asymptomatic suspected COVID-19 infection. Thrombosis J. 2020; 18: 19. doi:10.1186/s12959-020-00235-w.


Touré A, Donamou J, Camara A, Dramé B, BAH, O. Post-COVID-19 late pulmonary embolism in a young woman about a case. OJEM. 2020; 8(4): 79–85. doi: 10.4236/ojem.2020.84009.


Koche M, Bechmann S, Omoruyi IS. Bilateral pulmonary embolism in a discharged patient with resolved COVID-19 pneumonia. Cureus. 2020;12(7): e9406. doi:10.7759/cureus.9406.


Akiyama Y, Horiuchi K, Kondo Y, Kabata H, Ishii M, Fukunaga K. A case of non-severe COVID-19 complicated by pulmonary embolism. Respirol Case Rep. 2020;8(7): e00622. doi: 10.1002/rcr2.622.


Kanso M, Cardi T, Marzak H, Schatz A, Faucher L, Grunebaum L, et al. Delayed pulmonary embolism after COVID-19 pneumonia: a case report. Eur Heart J Case Rep. 2020;4(6):1-4. doi: 10.1093/ehjcr/ytaa449.


Vitali C, Minniti A, Caporali R, Del Papa N. Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19. Thromb Res. 2020; 192:21–2. doi: 10.1016/j.thromres.2020.05.002.


Bellieni A, Intini E, Taddei E, Baldi F, Larosa L, Murri R, et al.Challenges in COVID-19: Is pulmonary thromboembolism related to overall severity? Infect Dis (Lond). 2020; 52(8):585–9. doi: 10.1080/23744235.2020.1769854.


Tveita A, Hestenes S, Sporastřyl ER, Pettersen SA, Neple BL, Myrstad M, et al. Pulmonary embolism in cases of COVID-19. Tidsskr Nor Laegeforen. 2020; 140:0526. doi: 10.4045/tidsskr.20.0366.


Roberts LN, Whyte MB, GeorgiouL, Giron G, Czuprynska J, Rea C, et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020; 136 (11): 1347–50. doi: 10.1182/blood.2020008086.


Mouhat B, Besutti M, Bouiller K, Grillet F, Monnin C, Ecarnot F, et al. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. Eur Respir J. 2020;56(4):2001811. doi:10.1183/13993003.01811-2020.


Graziani A, Domenicali M, Zanframundo G, Palmese F, Caroli B, Graziani L: Pulmonary artery thrombosis in COVID-19 patients. Pulmonology. 2020:S2531-0437(20)30185-9. doi: 10.1016/j.pulmoe.2020.07.013. Epub ahead of print.


Cavagna E, Muratore F, Ferrari F. Pulmonary Thromboembolism in COVID-19: venous thromboembolism or arterial thrombosis? Radiol Cardiothorac Imaging. 2020. 9;2(4): e200289. doi: 10.1148/ryct.2020200289.


Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST Guideline and Expert Panel Report. Chest. 2020;158(3):1143-63. doi: 10.1016/j.chest.2020.05.559.


Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: Results from a prospective, single-center, clinicopathologic case series. Ann Intern Med. 2020;173(5):350–61. doi: 10.7326/M20-2566.


DOI: http://dx.doi.org/10.24125/sanamed.v16i1.501


  • There are currently no refbacks.

Copyright (c) 2021 Calin Pop, Ionut Ferent

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.